{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-021012","form_type":"8-K","ticker":"LUCD","cik":"0001799011","company_name":"Lucid Diagnostics Inc.","filed_at":"2022-08-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:57.067003+00:00","generated_at":"2026-06-24T06:03:37.310539+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Lucid Diagnostics appoints Debra J. White as Class C director effective August 1, 2022","bullets":["Debra J. White appointed to Board, replacing Aster Angagaw who resigned July 30; resignation not due to disagreement.","White received option to purchase 80,000 shares at $2.95/share, vesting in 12 quarterly installments starting Sept 30, 2022.","White also serves on board of parent PAVmed Inc.; joins nominating/corporate governance and audit committees."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-021012","json":"https://secwatch.observer/filing/0001493152-22-021012.json","markdown":"https://secwatch.observer/filing/0001493152-22-021012.md","text":"https://secwatch.observer/filing/0001493152-22-021012.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1799011/000149315222021012/0001493152-22-021012-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1799011/000149315222021012/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T06:03:37.310539+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"23ba6ae438","claim":"Debra J. White was appointed as Class C director at Lucid Diagnostics Inc..","evidence_excerpt":"appointed Debra J. White as a Class C director of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1799011/000149315222021012/0001493152-22-021012-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Class C director"}],"fact_type":"executive_change"},{"claim_id":"cf54e46f98","claim":"Aster Angagaw resigned as director at Lucid Diagnostics Inc..","evidence_excerpt":"Ms. White replaces Aster Angagaw, who resigned as a director effective on July 30, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1799011/000149315222021012/0001493152-22-021012-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}